Glycerin Suppositories USP
Natural health product licensed in Canada
- Licence holder
- Teva Canada Limited
- NPN or DIN-HM
- 00891053
- Status
- Active licence
- Licence date
- 24 October 2007
- Revision date
- 7 April 2022
- Form
- Suppositoire
- Route of administration
- Rectale
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Acide stéarique, Hydroxyde de sodium, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | maximum: 2 years | Not specified | Not specified |
| Enfants | minimum: 2 years | 1 Capsule | Not specified |
Uses authorised in Canada
Laxative for the rapid relief of occasional constipation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
N/A
- Effets indésirables connus
N/A
- Précautions et mises en garde
Do not take any type of laxative for more than one week unless your physician has ordered a special schedule for you. Do not use in presence of fever, nausea, vomiting or abdominal pain.
Source
Official Health Canada record, licence 00891053
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging